| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Virpax Pharmaceuticals Inc (NASDAQ: VRPX)
VRPX Technical Analysis
5
| As on 30th Dec 2025 VRPX STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.21 & Strong Sell for SHORT-TERM with Stoploss of 0.33 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VRPXSTOCK Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | -0.01 | -50.00 |
| Low | 0.01 | 1 Week | -0.01 | -50.00 |
| Close | 0.01 | 1 Month | -0.01 | -50.00 |
| Volume | 5236 | 1 Year | -0.45 | -97.83 |
| 52 Week High 2.07 | 52 Week Low 0.01 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| INTC | 45.55 | 10.80% |
| OCG | 0.02 | 0.00% |
| OPEN | 7.29 | 13.37% |
| NVDA | 184.86 | -0.10% |
| LMDX | 0.02 | 0.00% |
| PLUG | 2.19 | -5.60% |
| ONDS | 13.69 | -2.28% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VRPX Daily Charts |
VRPX Intraday Charts |
Whats New @ Bazaartrend |
VRPX Free Analysis |
|
|
VRPX Important Levels Intraday
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
VRPX Forecast January 2026
| 4th UP Forecast | 0.47 |
| 3rd UP Forecast | 0.32 |
| 2nd UP Forecast | 0.23 |
| 1st UP Forecast | 0.14 |
| 1st DOWN Forecast | -0.12 |
| 2nd DOWN Forecast | -0.21 |
| 3rd DOWN Forecast | -0.3 |
| 4th DOWN Forecast | -0.45 |
VRPX Weekly Forecast
| 4th UP Forecast | 0.36 |
| 3rd UP Forecast | 0.25 |
| 2nd UP Forecast | 0.18 |
| 1st UP Forecast | 0.11 |
| 1st DOWN Forecast | -0.09 |
| 2nd DOWN Forecast | -0.16 |
| 3rd DOWN Forecast | -0.23 |
| 4th DOWN Forecast | -0.34 |
VRPX Forecast2026
| 4th UP Forecast | 7.26 |
| 3rd UP Forecast | 4.93 |
| 2nd UP Forecast | 3.5 |
| 1st UP Forecast | 2.06 |
| 1st DOWN Forecast | -2.04 |
| 2nd DOWN Forecast | -3.48 |
| 3rd DOWN Forecast | -4.91 |
| 4th DOWN Forecast | -7.24 |
Virpax Pharmaceuticals Inc ( NASDAQ USA Symbol : VRPX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VRPX Business Profile
Virpax Pharmaceuticals, Inc., a preclinical stage biopharmaceutical company, develops and manufactures non-opioid and non-addictive pharmaceutical products using drug delivery systems for pain management. The company offers products, such as Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; Probudur (LBL100), long-acting bupivacaine liposomal gel for postoperative pain management; OSF200 for chronic osteoarthritis of the knee; and NES100 (Envelta), an exogenous enkephalin intranasal spray for acute and chronic pain. It also develops PES200 for the management of post-traumatic stress disorder; and MMS019 high-density molecular masking spray to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania. Address: 1055 Westlakes Drive, Berwyn, PA, United States, 19312
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service